Status:

RECRUITING

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

Lead Sponsor:

Shanghai Tong Ren Hospital

Conditions:

Acute Coronary Syndrome Patients With Diabetes After PCI

Eligibility:

All Genders

18-90 years

Phase:

PHASE4

Brief Summary

In this study, the investigates try to confirm the hypothesis that low dose ticagrelor(60mg) had similar anti-platelets function compared with the standard dose ticagrelor in acute coronary syndrome p...

Eligibility Criteria

Inclusion

  • Subject must be at least 18 years of age and less than 90 years old
  • Patients should have undergone successful percutaneous coronary intervention with drug-eluting stent for acute coronary syndrome with diabetes mellitus.
  • Subject understand the study requirements and the treatment procedures and
  • provided informed consent before the procedure

Exclusion

  • Female of childbearing potential, unless a recent pregnancy test is negative, who possibly plan to become pregnant any time after enrollment into this study
  • Active bleeding
  • Known hypersensitivity or contraindication to study medications
  • Female of childbearing potential, unless a recent pregnancy test is negative, who possibly plan to become pregnant any time after enrollment into this study
  • Non-cardiac co-morbid conditions are present with life expectancy \<2 year or that may result in protocol non-compliance (per site investigator's medical judgment).
  • Subjects with Cerebral hemorrhage history
  • Subjects with stroke history in half a year
  • subjects with active malignant tumor
  • subjects with whom oral anticoagulants are needed
  • Other conditions which the investigators think not applicable to the study.

Key Trial Info

Start Date :

April 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04307511

Start Date

April 20 2020

End Date

May 31 2024

Last Update

April 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

shanghai Tongren hospital

Shanghai, China, 200336